WINTON GROUP Ltd Acquires New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

WINTON GROUP Ltd purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 1,956 shares of the medical equipment provider's stock, valued at approximately $1,021,000.

Several other institutional investors have also recently made changes to their positions in ISRG. M.E. Allison & CO. Inc. bought a new position in Intuitive Surgical in the 4th quarter worth about $449,000. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $82,517,000. Sycomore Asset Management increased its position in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC raised its stake in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its position in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after purchasing an additional 525 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ISRG shares. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 18th. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Truist Financial cut their price objective on Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a report on Monday, March 17th. Bernstein Bank raised their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday, January 27th. Finally, Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $611.86.

Remove Ads

Intuitive Surgical Price Performance

Intuitive Surgical stock traded down $12.12 during mid-day trading on Thursday, reaching $494.93. 821,089 shares of the company traded hands, compared to its average volume of 1,526,286. The firm's 50 day moving average price is $550.11 and its 200 day moving average price is $532.84. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $176.28 billion, a price-to-earnings ratio of 77.21, a P/E/G ratio of 5.85 and a beta of 1.43.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.